Caplin Point Laboratories’ arm gets USFDA’s approval for Ephedrine Sulfate Injection

19 Jul 2024 Evaluate

Caplin Point Laboratories’ Subsidiary -- Caplin Steriles (Caplin) has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ephedrine Sulfate injection USP, 50 mg/mL Single Dose vial, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) AKOVAZ, from Exela Pharma Sciences LLC.

Ephedrine Sulfate injection USP, 50 mg/mL is indicated for the treatment of clinically important hypotension occurring in the setting of anaesthesia. According to IQVIA (IMS Health), Ephedrine Sulfate injection USP 50 mg/mL had US sales of approximately $36 million for the 12-month period ending May 2024.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.


Caplin Point Lab Share Price

2553.20 43.20 (1.72%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.